Elite Pharmaceuticals (ELTP) Cash & Current Investments (2010 - 2026)
Elite Pharmaceuticals' Cash & Current Investments was $39.42 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 77.6% from $22.2 million a year earlier and up 30.2% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Cash & Current Investments at Elite Pharmaceuticals came in at $30.27 million, up 157.2% from FY2025.
- Cash & Current Investments shows a five-year compound annual growth rate of 56.8% (FY2021 to FY2026).
- In earlier fiscal years, Cash & Current Investments was $11.77 million in FY2025 (+56.1%), $7.54 million in FY2024 (-8.6%), $8.24 million in FY2023 (-3.4%) and $8.54 million in FY2022 (+167.3%).
- The fiscal Q1 2027 figure marks the highest quarterly Cash & Current Investments in data going back to fiscal Q1 2011.
- Compared with a year earlier, Cash & Current Investments has increased for eight straight quarters, with growth averaging 101.2% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was fiscal Q2 2023 (growth of 313.2%); the worst was fiscal Q3 2024 (a decline of 65.1%).
- Per Business Quant data, ELTP's Cash & Current Investments in the three fiscal quarters before Q1 2027 was $30.27 million (Q4 2026), $21.56 million (Q3 2026) and $27.08 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Elite Pharmaceuticals | 244.53 Mn | 126.20 Mn | 13.51 Mn | 39.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.42 Mn |
| Mar 31, 2026 | 30.27 Mn |
| Dec 31, 2025 | 21.56 Mn |
| Sep 30, 2025 | 27.08 Mn |
| Jun 30, 2025 | 22.20 Mn |
| Mar 31, 2025 | 11.77 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 8.85 Mn |
| Mar 31, 2024 | 7.54 Mn |
| Dec 31, 2023 | 6.24 Mn |
| Sep 30, 2023 | 9.08 Mn |
| Jun 30, 2023 | 9.49 Mn |
| Mar 31, 2023 | 8.24 Mn |
| Dec 31, 2022 | 17.91 Mn |
| Sep 30, 2022 | 18.56 Mn |
| Mar 31, 2022 | 8.54 Mn |
| Dec 31, 2021 | 7.29 Mn |
| Sep 30, 2021 | 4.49 Mn |
| Jun 30, 2021 | 4.75 Mn |
API Access
Elite Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();